ocular disorder
Axim Biotechnologies, Versea Ophthalmics Partner to Commercialize Eye Disease Tests
Versea will have the exclusive commercial right to Axim's point-of-care readers and three diagnostic tests for eye disease.
Avellino Labs Gets CLIA Certification
With the certification, the Silicon Valley-based company aims to roll out its AvaGen test for keratoconus and corneal dystrophies beginning this quarter.
Bluejay Diagnostics Gets CE Mark for Allergic Conjunctivitis Test
Bluejay's point-of-care test is designed to measure the presence of human immunoglobulin E in a tear sample, providing results within 10 minutes.